TBPH Theravance Biopharma, Inc.
Healthcare$16.41+0.24%ClosedMarket Cap: $846.0M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$27.00
Target (Median)
$27.00
Target Range
$14.00 - $40.00
Upside from current price: 64.5%
Rating Distribution
0 Strong Buy3 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-07 | B. Riley Securities | maintain | Neutral | Neutral |
| 2026-03-23 | TD Cowen | maintain | Hold | Hold |
| 2026-03-20 | BTIG | maintain | Buy | Buy |
| 2026-03-05 | Oppenheimer | downgrade | Perform | Outperform |
| 2026-03-04 | B. Riley Securities | downgrade | Neutral | Buy |
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-03 | BTIG | maintain | Buy | Buy |
| 2025-11-26 | BTIG | maintain | Buy | Buy |
| 2025-11-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-27 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.35 | $97.3M | 3 |
| Sun Dec 31 | $0.81 | $93.0M | 5 |
| Mon Dec 31 | $0.91 | $97.4M | 1 |
| Tue Dec 31 | $1.11 | $102.7M | 1 |